CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/30/2021
Back to search
Official data from USPTO
ONCOLYTICS BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOLYTICS BIOTECH
ST13
US500000077240455Class
5, 42
Filing
77240455
Registration
3555516
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
12/30/2021
Trademark type
Word
Nice classes
5, 42
Filing date
07/27/2007
Registration date
12/30/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/19/2018
Last transaction
04/19/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Foreign priority
First use anywhere
07/21/2000
First use in commerce
11/14/2005
Drawing code
4
Owner type
03
Owner location
Calgary, Alberta, CA
Examiner
JACKSON, STEVEN W
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Oncolytics Biotech Inc.
Oncolytics Biotech Inc.
Representatives
Cynthia Johnson Walden FISH & RICHARDSON P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
HOUSEMARK FOR PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CANCER
Class 42
MEDICAL AND SCIENTIFIC RESEARCHCONDUCTING CLINICAL TRIALS; MEDICAL AND SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF CANCER TREATMENT
Publications
History of USPTO decisions and trademark events.
42 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/30/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/30/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/30/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/30/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/19/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/19/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/19/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/19/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
04/09/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/30/2017
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/31/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/31/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/27/2014
ES8R
TEAS SECTION 8 RECEIVED
12/19/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/22/2010
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/30/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/25/2008
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/25/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2008
ALIE
ASSIGNED TO LIE
11/05/2008
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/24/2008
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/07/2008
GNFR
FINAL REFUSAL E-MAILED
10/07/2008
CNFR
FINAL REFUSAL WRITTEN
10/07/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2008
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/02/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/13/2008
GNSL
LETTER OF SUSPENSION E-MAILED
05/13/2008
CNSL
SUSPENSION LETTER WRITTEN
05/13/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/24/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/24/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/24/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/02/2007
GNRT
NON-FINAL ACTION E-MAILED
11/02/2007
CNRT
NON-FINAL ACTION WRITTEN
11/02/2007
DOCK
ASSIGNED TO EXAMINER
11/02/2007
NWAP
NEW APPLICATION ENTERED
07/31/2007
Continuous trademark protection
Get notified about every new filing that threatens ONCOLYTICS BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.